期刊文献+

5/6肾切除大鼠残肾组织HIF-1α、nNOS蛋白表达及丹参多酚酸盐的作用机制 被引量:7

原文传递
导出
摘要 慢性氧缺失是促进慢性肾脏病进展和纤维化的重要原因。丹参多酚酸盐可显著改善肾功能,但其确切机制尚不明确。本研究通过构建5/6肾切除肾衰竭大鼠模型,从肾氧耗及细胞与分子水平等探讨丹参多酚酸盐改善肾功能、抗肾纤维化的作用机制。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2014年第2期147-148,共2页 Chinese Journal of Nephrology
基金 国家自然科学基金(30973723) 教育部博士学科点专项基金(2012310711004) 上海市中医药事业发展三年行动计划(ZYSNXD-CC-MZY044)
  • 相关文献

参考文献9

  • 1Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeuticsIJ]. Kidney Int, 2008, 74: 867-872.
  • 2Eckardt KU, Bernhardt WM, Weidemann A, et al. Role of hypoxia in the pathogenesis of renal disease[J]. Kidney Int Suppl, 2005, 99: S46-S51.
  • 3徐曼,王逸平,孙伟康,宣利江,徐亚明.丹参多酚酸盐对大鼠慢性肾衰时肾功能及内源性内皮素释放的影响[J].中国药理学与毒理学杂志,2001,15(1):39-42. 被引量:76
  • 4侯凡凡.肾脏慢性纤维化的最新研究对临床防治的启迪[J].解放军医学杂志,2008,33(1):6-7. 被引量:13
  • 5Manotham K, Tanaka T, Matsumoto M, et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model [J]. J Am Soc Nephrol, 2004, 15: 1277-1288.
  • 6Ma YY, Sun D, Li J, et al. Transplantation of endothelia progenitor cells alleviates renal interstitial fibrosis in a mouse model of ureteral obstruction[J]. Life Sci, 2010, 86: 798-807.
  • 7Nangaku M, Inagi R, Miyata T, et al. Hypoxia and hypoxia- inducible factor in renal disease[J]. Nephron Exp Nephrol, 2008, 110: e1-e7.
  • 8Antunes F, Boveris A, Cadenas E. On the meehanism and biology of cytochrome oxidase inhibition by nitric oxide[J]. Proc Natl Acad Sci USA, 2004, 101: 16774-16779.
  • 9Deng A, Tang T, Singh P, et al. Regulation of oxygen utilization by angiotensin II in ehronic kidney disease[J]. Kidney Int, 2009, 75: 197-204.

二级参考文献15

  • 1杨小兵,侯凡凡,武强,周华,刘郑荣,杨燕,张训.慢性肾脏病患者晚期氧化蛋白产物血症及其与动脉粥样硬化的关系[J].中华内科杂志,2005,44(5):342-346. 被引量:41
  • 2林善炎,中华医学杂志,1992年,72卷,4期,201页
  • 3Yokozawa T,J Pharm Pharmacol,1990年,42卷,10期,712页
  • 4Yokozawa T,Chem Pharm Bull,1988年,36卷,1期,316页
  • 5Collins AJ, Couser WG, Dirks JH, et al. World Kidney Day: an idea whose time has come Kidney Int, 2006, 69(5): 781
  • 6Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atheroselerosis through promoting oxidative stress and inflarmnation. Arterioscler Thromb Vase Biol, 2006,26(5) : 1156
  • 7Li HY, Hou FF, Zhang X, et al. Advanced oxidation protein products accelerate fibrosis in a remnant kidney model. J Am Soc Nephrol, 2007,18(2) : 528
  • 8Hou FF, Ren H, Owen WFJr, et al. Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol, 2004, 15(7): 1889
  • 9Li JT, Hou FF, Guo ZJ, et al. Advanced glycation end products upregulate C-reactive protein synthesis by human hepatocytes through stimulation of monocyte IL-6 and IL-113 production. Stand J Immunol, 2007, 66(5) : 555
  • 10Feng JX, Hou FF, Liang M, et al. Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. Kidney Int, 2007, 71(9): 901

共引文献87

同被引文献83

引证文献7

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部